Parvathy Hospital Conducts Unique Complicated Surgery Treating Crushed Arm

IMT News Desk
IMT News Desk
· 3 min read

Chennai, 28th August 2019: Parvathy Hospital, Chennai today announced that they had successfully conducted a unique complicated multiple surgical treatment to a 20-year-old female patient who sustained serious crush injury in her right arm with wrist drop due to Radial nerve injury, following a road traffic accident. A team of Orthopedic surgeons, Plastic surgeons headed by Dr. Dharmarajan, Director of Orthopedic Surgery, Dr. Mithun, Sr. Orthopaedic surgeon, and Dr. Arul, Sr. Plastic surgeon Parvathy Hospital, Chennai performed challenging procedures which enabled the patient to regain her hand mobility and successfully by avoiding upper limb amputation. 

The young female patient, Ms. Ponniyammal, a resident of Kancheepuram, had earlier met with a road accident sustained serious crush injury. She also suffered a nerve cut and was unable to move her hand and lost her sensation. A team of orthopaedic doctors, Plastic surgeons examined the patient and found her right upper limb sustained crush injury and radial nerve injury. A comminuted compound fracture of right proximal humerus with wrist drop was also diagnosed and series of surgical procedures done. 

Elaborating the procedures, Dr. Mithun, Sr. Orthopaedic Surgeon, Parvathy Hospital said, “The patient was observed with a complete right arm crush and had loss of movement as well as sensation. Initially temporary stabilization of fracture done with external fixator and series of wound debridement procedures were performed by plastic surgeons’ team for removal of necrotic tissue and to promote wound healing, stage by stage in her right arm. Such debridement procedures were necessary to remove the dead material in her arm. Later SSG, the split skin grafting procedure was performed to cover deep structures, restore dynamic function of the arm and to prevent joint contractures”.

Further Dr Mithun said, “After a month of observation, an Open reduction and internal fixation (ORIF) and bone grafting was performed to reconstruct the broken bones to bring them back to the normal position. This is an extremely complex situation in which we had successfully operated to heal properly and to regain normal function of her upper limb. 

Dr. Dharmarajan, Director of Orthopedic Surgeon, Parvathy Hospital said, “The treatment procedures were safe, rapid and very cost effective. It was a challenging task to reconstruct and to regain the mobility inspite of severe crush injury with nerve injury. We finally saved her crushed arm, the comminuted fractures healed well with reasonable functions in her upper limb. With these procedures, we avoided any kind of upper limb amputation thereby saving girl’s future”

Speaking on her recovery, the patient said, “In spite of severe crush injury (for which amputation was suggested in other hospital), Doctors at Parvathy Hospital performed treatment by which I regained my upper limb and able to move my hand. I am confident that sooner I can resume my natural work.”

Read Next

Akums Reports Strong Q4 FY26 Performance; EBITDA Surges 62%, Board Recommends Dividend
News
May 15, 2026

Akums Reports Strong Q4 FY26 Performance; EBITDA Surges 62%, Board Recommends Dividend

Akums Drugs & Pharmaceuticals Ltd., India’s largest Contract Development and Manufacturing Organisation (CDMO), has reported a robust financial performance for the fourth quarter and full year ended March 31, 2026, driven by strong growth in its core CDMO business and improved operational efficiencies. Q4 FY26: Profitability Outpaces Revenue Growth Akums posted an operating revenue of […]
Article by: IMT News Desk
Alembic Pharmaceuticals announces USFDA Tentative Approval for Darolutamide Tablets
News
May 14, 2026

Alembic Pharmaceuticals announces USFDA Tentative Approval for Darolutamide Tablets

Alembic Pharmaceuticals Limited (Alembic) has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Darolutamide Tablets, 300 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Nubeqa Tablets, 300 mg, of Bayer HealthCare Pharmaceuticals Inc. (Bayer). Darolutamide is an androgen […]
Article by: IMT News Desk
Lilly launches Lormalzi® (Donanemab) for the treatment of early symptomatic Alzheimer’s Disease in India
News
May 14, 2026

Lilly launches Lormalzi® (Donanemab) for the treatment of early symptomatic Alzheimer’s Disease in India

Eli Lilly and Company (India) Pvt. Ltd. has announced the launch of Lormalzi® (donanemab, 350 mg/20 mL IV vial) in India, following marketing authorisation from the Central Drugs Standard Control Organization (CDSCO) for the treatment of Alzheimer’s disease with mild cognitive impairment or those in the mild dementia stage of disease. Lormalzi® is the first […]
Article by: IMT News Desk
Stryker and Max Smart Hospital, Saket Partner to Advance Surgeon Training and Education in Robotic-Arm Assisted Joint Replacement
News
May 14, 2026

Stryker and Max Smart Hospital, Saket Partner to Advance Surgeon Training and Education in Robotic-Arm Assisted Joint Replacement

Stryker and Max Smart Super Speciality Hospital, Saket, announced a strategic collaboration to advance surgeon training, clinical education, and patient care in robotic-arm-assisted joint replacement in India. As part of this collaboration, Max Smart Super Speciality Hospital, Saket, will serve as a training and education center for orthopaedics. The collaboration aims to support the evolving joint replacement ecosystem […]
Article by: IMT News Desk